Broadcom (AVGO) call put ratio 1.4 calls to 1 put into quarter results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/8/2026
- S&P 500 falls as AI worries hit software makers
- Brent crude hits six-week high near $97 as Houthi strike targets Saudi Aramco
- Qualcomm stock surges 9.5% on Amazon AI deal & 25M share warrant
- Energy stocks rise premarket as oil prices climb on Middle East supply fears
- Novartis shares plunge 10% as failed drug trial clouds growth outlook
- Citi initiates UiPath coverage with Buy rating and $23 target
- Harry and Meghan surprised by King Charles' letter on their status
- WestPark Capital Starts Akebia Therapeutics (AKBA) at Buy
- S&P 500 falls as AI worries hit software makers
- After an 18% summer selloff in chip stocks, Citi asks what comes next
- After-Hours Movers: LULU, IOT, PATH, DOCU, ASAN, GWRE, ZS, PL, SWBI, OXM
- After-Hours Movers: AVGO, SNOW, HPE, NTAP, NTSK, CHPT, FIVE, TLYS, PVH, RARE
- After-Hours Movers: DELL, PANW, GTLB, CRDO, MDB, HPE, SMCI
- After-Hours Movers: WDAY, ADSK, S, RBRK, MRVL, ULTA, GAP, AFRM
- After-Hours Movers: NVDA, CRM, SNPS, CRWD, OKTA, NTNX
Broadcom Limited (AVGO) PT Raised to $295 at Truist Securities, 'Buy the near-term weakness'
June 6, 2025 7:06 AM EDTTruist Securities analyst William Stein raised the price target on Broadcom Limited (NASDAQ: AVGO) to $295.00 (from $267.00) while maintaining a Buy rating.
The analyst comments "Buy the near-term weakness. AVGO posted very modest upside to CQ1 (Apr) results, and CQ2 (July) guidance.... More
Broadcom Limited (AVGO) PT Raised to $325 at JPMorgan
June 6, 2025 5:16 AM EDTJPMorgan analyst Harlan Sur raised the price target on Broadcom Limited (NASDAQ: AVGO) to $325.00 (from $250.00) while maintaining a Overweight rating.
The analyst comments "We see the recent ruling from the U.S. District Court for the District of Delaware in favor of ACAD regarding its 721 formulation patent for Nuplazid (pimavanserin) on both infringement and validity arguments against Aurobindo Pharma and other ANDA filers (see document here) as a clear positive. Note that the 721 patent provides protection for the Nuplazid 34mg capsule formulation into 2038. We believe it is logical to assume the parties... More
Broadcom Limited (AVGO) PT Raised to $304 at Evercore ISI, 'We’re Still Buyers'
June 6, 2025 4:54 AM EDTEvercore ISI analyst Mark Lipacis raised the price target on Broadcom Limited (NASDAQ: AVGO) to $304.00 (from $267.00) while maintaining a Outperform rating.
The analyst comments "Were Still Buyers of AVGO after an in-line AprQ print and implied EPS outlook that is $0.01 below consensus. AI revs... More
Broadcom Limited (AVGO) PT Raised to $315 at KeyBanc
June 6, 2025 4:49 AM EDTKeyBanc analyst John Vinh raised the price target on Broadcom Limited (NASDAQ: AVGO) to $315.00 (from $275.00) while maintaining a Overweight rating.
The analyst comments "AVGO reported solid F2Q (Apr) results and provided mixed F3Q (Jul) guidance (higher revs, lower... More
